AbbVie (ABBV) News Today $192.50 +1.00 (+0.52%) As of 10:07 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why is AbbVie Up Today?AbbVie Inc. (ABBV) shares have increased amid a wave of analyst upgrades and key regulatory approvals, though legal developments and calls for further catalysts temper the outlook. Cantor Fitzgerald raises FY2026 EPS estimate to $14.12 (vs. consensus $12.31), retains “Overweight” rating with $210 price target U.S. FDA expands Mavyret label twice: now approved for pediatric hepatitis C patients (age 3+) and for acute HCV as the first eight-week pangenotypic oral therapy Citigroup boosts its price target to $205 (7.2% upside) with a “Hold” rating; Bank of America sets a $204 target Consensus “Moderate Buy” from 27 brokerages (16 buys, 8 holds) underscores broad analyst support Various brokers issue FY2026 earnings forecasts, reflecting mixed—but generally optimistic—outlooks AbbVie’s presentation at the Goldman Sachs 46th Annual Global Healthcare Conference highlighted pipeline progress and commercial strategy Zacks notes ABBV as a trending stock, driven by investor interest in its growth profile and dividend yield AbbVie sues North Dakota over a new drug‐pricing law, adding legal and regulatory uncertainty Despite FDA wins, some retail investors say they need broader commercial catalysts beyond label expansions Posted 36m agoAI Generated. May Contain Errors. ABBV Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Compagnie Lombard Odier SCmA Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV)Compagnie Lombard Odier SCmA lessened its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 4.1% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 343,159 shares of the company's stoJune 12 at 9:10 AM | marketbeat.comFort Washington Investment Advisors Inc. OH Sells 42,337 Shares of AbbVie Inc. (NYSE:ABBV)Fort Washington Investment Advisors Inc. OH cut its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 15.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 226,891 shares of the company's stJune 12 at 8:58 AM | marketbeat.comMogy Joel R Investment Counsel Inc. Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)Mogy Joel R Investment Counsel Inc. trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 12.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 45,761 shares of the company's stock after selliJune 12 at 8:48 AM | marketbeat.comFerguson Wellman Capital Management Inc. Has $133.95 Million Holdings in AbbVie Inc. (NYSE:ABBV)Ferguson Wellman Capital Management Inc. raised its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 639,293 shares of the coJune 12 at 8:29 AM | marketbeat.comFortitude Family Office LLC Sells 2,703 Shares of AbbVie Inc. (NYSE:ABBV)Fortitude Family Office LLC lessened its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 26.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,647 shares of the company's stock after sellJune 12 at 8:20 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Davis Investment Partners LLCDavis Investment Partners LLC lifted its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 28.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,891 shares of the company's stock after acquiring an adJune 12 at 8:01 AM | marketbeat.comSapient Capital LLC Has $48.21 Million Position in AbbVie Inc. (NYSE:ABBV)Sapient Capital LLC lessened its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 11.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 230,088 shares of the company's stock after selling 28,811 shares during theJune 12 at 8:01 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Fifth Third BancorpFifth Third Bancorp decreased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,440,477 shares of the company's stockJune 12 at 7:03 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Purchased by Simon Quick Advisors LLCSimon Quick Advisors LLC boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 14.1% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 21,705 shares of the company's stock after acquiring an additional 2,688 shares during the period. SimonJune 12 at 7:02 AM | marketbeat.comAxecap Investments LLC Has $4.39 Million Stake in AbbVie Inc. (NYSE:ABBV)Axecap Investments LLC trimmed its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 12.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 20,969 shares of the company's stock after selling 2,870 shares during the period. AbbVie accounts for approximatelyJune 12 at 6:53 AM | marketbeat.comZhang Financial LLC Grows Holdings in AbbVie Inc. (NYSE:ABBV)Zhang Financial LLC grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 27.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 24,214 shares of the company's stock after purchasing an additionalJune 12 at 6:32 AM | marketbeat.comAvanza Fonder AB Has $1.40 Million Stake in AbbVie Inc. (NYSE:ABBV)Avanza Fonder AB decreased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 19.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 6,825 shares of the company's stock after selling 1,618 shares during the period. Avanza FonderJune 12 at 5:25 AM | marketbeat.comBrokers Issue Forecasts for AbbVie FY2026 EarningsJune 12 at 4:05 AM | americanbankingnews.comAbbVie Stock Rises After FDA Approves Expanded Treatment Scope For Mavyret, But Retail Needs More To CheerJune 12 at 12:54 AM | msn.comFDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C InfectionJune 11 at 2:27 PM | benzinga.comU.S. FDA Approves Expanded Indication for AbbVie's MAVYRET® (Glecaprevir/Pibrentasvir) as First and Only Treatment for People with Acute Hepatitis C VirusJune 11 at 12:31 PM | prnewswire.comAbbVie (NYSE:ABBV) Given New $205.00 Price Target at CitigroupCitigroup raised their price objective on shares of AbbVie to $205.00 and gave the company a "hold" rating in a research note on Wednesday.June 11 at 10:37 AM | marketbeat.comThompson Investment Management Inc. Trims Stock Position in AbbVie Inc. (NYSE:ABBV)Thompson Investment Management Inc. decreased its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 13.9% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 33,143 shares of the company's stock after selling 5,362 shares during tJune 11 at 9:02 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) is Alpha Omega Wealth Management LLC's 6th Largest PositionAlpha Omega Wealth Management LLC lowered its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 9.1% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 49,695 shares of the company'June 11 at 8:52 AM | marketbeat.comTransform Wealth LLC Sells 3,738 Shares of AbbVie Inc. (NYSE:ABBV)Transform Wealth LLC reduced its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 4.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 90,628 shares of the company's stock after selling 3,738 shares during the quarter. AbbVie comprises approximatJune 11 at 8:21 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Donaldson Capital Management LLCDonaldson Capital Management LLC grew its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 480,632 shares of the company's stock afterJune 11 at 8:00 AM | marketbeat.comCharis Legacy Partners LLC Invests $387,000 in AbbVie Inc. (NYSE:ABBV)Charis Legacy Partners LLC purchased a new position in AbbVie Inc. (NYSE:ABBV - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 1,848 shares of the company's stock, valued at approximately $387,000. AbJune 11 at 7:34 AM | marketbeat.comCurbstone Financial Management Corp Buys 2,233 Shares of AbbVie Inc. (NYSE:ABBV)Curbstone Financial Management Corp raised its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 20.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,932 shares of the company's stock afterJune 11 at 7:26 AM | marketbeat.comRowlandmiller & PARTNERS.ADV Decreases Stake in AbbVie Inc. (NYSE:ABBV)Rowlandmiller & PARTNERS.ADV trimmed its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 3.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 45,564 shares of the company's stock after selling 1,695 shares duriJune 11 at 7:25 AM | marketbeat.comAssenagon Asset Management S.A. Sells 1,323,453 Shares of AbbVie Inc. (NYSE:ABBV)Assenagon Asset Management S.A. lessened its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 66.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 665,533 shares of the company's stock after selling 1,323,453 shares durJune 11 at 6:54 AM | marketbeat.comMonarch Capital Management Inc. Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV)Monarch Capital Management Inc. cut its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.1% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 51,343 shares of the company's stock after selling 1,616 shares during the period. AbbVie makes up about 3.0%June 11 at 6:52 AM | marketbeat.comMV Capital Management Inc. Has $56.79 Million Stake in AbbVie Inc. (NYSE:ABBV)MV Capital Management Inc. lifted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 271,023 shares of the company's stock after buying an additional 4,339 shares during the period.June 11 at 6:43 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Franklin Street Advisors Inc. NCFranklin Street Advisors Inc. NC reduced its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 1.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 155,679 shares of the company's stock after selling 1,896 sharJune 11 at 6:42 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Integrated Advisors Network LLCIntegrated Advisors Network LLC increased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 25.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 53,458 shares of the company's stock after purchasingJune 11 at 6:30 AM | marketbeat.comAtwood & Palmer Inc. Sells 4,555 Shares of AbbVie Inc. (NYSE:ABBV)Atwood & Palmer Inc. lessened its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 2.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 191,348 shares of the company's stock after selling 4,555 shares durinJune 11 at 6:30 AM | marketbeat.comHarbor Capital Advisors Inc. Purchases New Stake in AbbVie Inc. (NYSE:ABBV)Harbor Capital Advisors Inc. purchased a new stake in AbbVie Inc. (NYSE:ABBV - Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 24,934 shares of the company's stock, valued at approximately $5,224,00June 11 at 5:26 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Given Consensus Rating of "Moderate Buy" by BrokeragesAbbVie Inc. (NYSE:ABBV - Get Free Report) has earned an average rating of "Moderate Buy" from the twenty-seven ratings firms that are currently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a hold recommendation, sixteen have assigned a buy recommendation aJune 11 at 2:44 AM | marketbeat.comAbbVie Inc. (ABBV) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptJune 11 at 2:10 AM | seekingalpha.comAbbVie (NYSE:ABBV) Given New $204.00 Price Target at Bank of AmericaJune 11 at 2:09 AM | americanbankingnews.comBrokers Offer Predictions for AbbVie FY2026 EarningsAbbVie Inc. (NYSE:ABBV - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of AbbVie in a report released on Monday, June 9th. Cantor Fitzgerald analyst C. Gould forecasts that the company will post earnings per share of $14.12 for the year. CanJune 10 at 9:46 AM | marketbeat.comHandelsbanken Fonder AB Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV)Handelsbanken Fonder AB increased its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 0.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,197,543 shares of the company's stock after purchasing an additional 6,336 shareJune 10 at 8:36 AM | marketbeat.comSanibel Captiva Trust Company Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)Sanibel Captiva Trust Company Inc. boosted its position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 3.3% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 264,608 shares of the company's stock after acquiring an additional 8,527 shares dJune 10 at 8:12 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Bought by Abacus FCF Advisors LLCAbacus FCF Advisors LLC grew its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 2.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 108,132 shares of the company's stock aftJune 10 at 7:37 AM | marketbeat.comParsons Capital Management Inc. RI Reduces Stake in AbbVie Inc. (NYSE:ABBV)Parsons Capital Management Inc. RI lowered its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 3.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 107,159 shares of the company's stockJune 10 at 7:28 AM | marketbeat.comFirst National Bank of Mount Dora Trust Investment Services Has $9.97 Million Stake in AbbVie Inc. (NYSE:ABBV)First National Bank of Mount Dora Trust Investment Services lowered its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 16.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,562June 10 at 7:17 AM | marketbeat.comCrescent Sterling Ltd. Sells 2,111 Shares of AbbVie Inc. (NYSE:ABBV)Crescent Sterling Ltd. lessened its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 10.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,581 shares of the company's stock after selling 2,111 sharJune 10 at 7:05 AM | marketbeat.comAccurate Wealth Management LLC Raises Holdings in AbbVie Inc. (NYSE:ABBV)Accurate Wealth Management LLC grew its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 27.2% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 17,066 shares of the company's stock after buying an additional 3,653 shares during the quarter. Accurate Wealth ManagJune 10 at 6:57 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Stock Position Raised by Prairie Sky Financial Group LLCPrairie Sky Financial Group LLC grew its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 14.6% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 93,511 shares of the company's stock after purchasing an additionalJune 10 at 6:56 AM | marketbeat.comSimplicity Wealth LLC Purchases 14,576 Shares of AbbVie Inc. (NYSE:ABBV)Simplicity Wealth LLC boosted its stake in AbbVie Inc. (NYSE:ABBV - Free Report) by 266.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 20,043 shares of the company's stock after purchasing an additional 14,576 sharesJune 10 at 6:48 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Sold by Yousif Capital Management LLCYousif Capital Management LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 1.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 243,198 shares of the company's stock after sellingJune 10 at 6:11 AM | marketbeat.comFarther Finance Advisors LLC Grows Position in AbbVie Inc. (NYSE:ABBV)Farther Finance Advisors LLC boosted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 49.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 34,192 shares of the company's stock after purchasing anJune 10 at 5:50 AM | marketbeat.comBank of America Issues Positive Forecast for AbbVie (NYSE:ABBV) Stock PriceBank of America lifted their target price on shares of AbbVie to $204.00 and gave the company a "hold" rating in a research note on Monday.June 9 at 9:27 AM | marketbeat.comTounjian Advisory Partners LLC Makes New Investment in AbbVie Inc. (NYSE:ABBV)Tounjian Advisory Partners LLC purchased a new position in shares of AbbVie Inc. (NYSE:ABBV - Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 16,290 shares of the company's stock, valued at approximately $3June 9 at 8:28 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Portside Wealth Group LLCPortside Wealth Group LLC increased its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 19.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 18,119 shares of the company's stock after purchasing an addJune 9 at 7:42 AM | marketbeat.comAbbVie Inc. (NYSE:ABBV) Shares Acquired by Moss Adams Wealth Advisors LLCMoss Adams Wealth Advisors LLC lifted its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 32.5% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,237 shares of the company's stock after purchasingJune 9 at 7:42 AM | marketbeat.com Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address ABBV Media Mentions By Week ABBV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABBV News Sentiment▼1.360.87▲Average Medical News Sentiment ABBV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABBV Articles This Week▼8056▲ABBV Articles Average Week Get AbbVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ABBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LLY News Today JNJ News Today MRK News Today PFE News Today BMY News Today ZTS News Today RPRX News Today CORT News Today JAZZ News Today PRGO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABBV) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ABBV Stock Free ABBV Stock Alerts